Enwei Pharmaceutical Co., Ltd. (SHE:301331)
25.68
-0.83 (-3.13%)
At close: May 21, 2026
-3.13% (1Y)
| Market Cap | 2.62B -3.5% |
| Revenue (ttm) | 879.60M +6.6% |
| Net Income | 48.14M +6.1% |
| EPS | 0.46 +2.7% |
| Shares Out | 101.88M |
| PE Ratio | 55.39 |
| Forward PE | n/a |
| Dividend | 0.66 (2.49%) |
| Ex-Dividend Date | Jan 8, 2026 |
| Volume | 1,244,280 |
| Average Volume | 1,159,501 |
| Open | 26.60 |
| Previous Close | 26.51 |
| Day's Range | 25.61 - 26.88 |
| 52-Week Range | 24.10 - 39.66 |
| Beta | 0.61 |
| RSI | 39.30 |
| Earnings Date | Apr 27, 2026 |